☆ 4.5 Letter

Seroconversion and indolent course of COVID-19 in patients with multiple sclerosis treated with fingolimod and teriflunomide

JOURNAL OF THE NEUROLOGICAL SCIENCES (2020)

Journal

JOURNAL OF THE NEUROLOGICAL SCIENCES

Volume 416, Issue -, Pages -

Publisher

ELSEVIER

DOI: 10.1016/j.jns.2020.117011

Keywords

Multiple sclerosis; Teriflunomide; Fingolimod; COVID-19; Seroconversion; Antibodies

Categories

Clinical Neurology Neurosciences

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.